Get the Stockscreener App
1.45
9.38%
-0.15
Cibus Inc stock is traded at $1.45, with a volume of 289.23K.
It is down -9.38% in the last 24 hours and up +0.69% over the past month.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
See More
Previous Close:
$1.60
Open:
$1.6
24h Volume:
289.23K
Relative Volume:
0.77
Market Cap:
$78.64M
Revenue:
$1.82M
Net Income/Loss:
$-267.63M
P/E Ratio:
-0.0719
EPS:
-20.1639
Net Cash Flow:
$-50.53M
1W Performance:
-12.13%
1M Performance:
+0.69%
6M Performance:
-35.56%
1Y Performance:
-67.05%
1-Day Range:
$1.43
$1.60
1-Week Range:
$1.43
$1.69
52-Week Range:
$1.20
$6.10
Cibus Inc Stock (CBUS) Company Profile
Name
Cibus Inc
Sector
Industry
Phone
(858) 450-0008
Address
6455 NANCY RIDGE DRIVE, SAN DIEGO
Compare CBUS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.4499 | 84.06M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.69 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.66 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
433.28 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
821.30 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.74 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | Alliance Global Partners | Buy |
| Jul-19-24 | Resumed | Canaccord Genuity | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Resumed | Canaccord Genuity | Buy |
Cibus Inc Stock (CBUS) Latest News
Why Cibus Inc. stock appeals to dividend seekersWeekly Trend Recap & High Conviction Buy Zone Alerts - newser.com
Best data tools to analyze Cibus Inc. stockWeekly Market Report & Daily Technical Stock Forecast Reports - newser.com
How Cibus Inc. stock performs in stagflationWeekly Stock Summary & Entry Point Confirmation Signals - newser.com
Should you hold or exit Cibus Inc. nowEarnings Growth Summary & Entry and Exit Point Strategies - newser.com
Applying chart zones and confluence areas to Cibus Inc.Chart Signals & Momentum Based Trading Ideas - newser.com
Is Cibus Inc. stock a safe buy before earningsWeekly Risk Summary & Growth Focused Stock Pick Reports - newser.com
Will Cibus Inc. stock deliver shareholder valueWeekly Volume Report & Low Risk Entry Point Tips - newser.com
Custom watchlist performance reports with Cibus Inc.Trade Analysis Summary & Daily Profit Focused Stock Screening - newser.com
Heatmap analysis for Cibus Inc. and competitorsPortfolio Value Report & Real-Time Market Trend Scan - newser.com
Will Cibus Inc. stock benefit from sector rotationPortfolio Gains Summary & Daily Price Action Insights - newser.com
Does Cibus Inc. fit your quant trading model2025 Short Interest & Daily Technical Stock Forecast Reports - newser.com
Identifying reversal signals in Cibus Inc.Weekly Investment Report & Fast Momentum Entry Tips - newser.com
Is Cibus Inc. stock supported by innovation pipelineMarket Growth Summary & Verified Entry Point Signals - newser.com
Will Cibus Inc. outperform the market2025 Earnings Surprises & High Accuracy Investment Entry Signals - newser.com
Is Cibus Inc. stock reversal real or fakePortfolio Risk Report & Safe Entry Zone Tips - newser.com
Can you recover from losses in Cibus Inc.Weekly Investment Report & Fast Entry Momentum Alerts - newser.com
Cibus (CBUS) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Cibus to Report Third Quarter 2025 Financial Results on November 13, 2025 After the Market Close and Host Conference Call - The Manila Times
Will Cibus Inc. rebound enough to break evenWeekly Volume Report & Entry Point Confirmation Signals - newser.com
Why Cibus Inc. stock remains a top recommendationJuly 2025 Trends & Weekly Top Performers Watchlists - Fundação Cultural do Pará
Cibus and AgVayā Partner to Boost Rice Productivity in India with Advanced Gene Editing Technology - global-agriculture.com
Cibus Inc Stock (CBUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.46%
7.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):